Establishment and characterization of urothelial carcinoma cell lines with and without BRAF mutation (V595E) in dogs

Allstadt SD, Roddriguez CO Jr, Boostrom B, Rebhum RB, Skorupski KA (2015) Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs. J Vet Intern Med 29:261–267

Article  CAS  Google Scholar 

Cekanova M, Uddin MD, Bartges JW, Callens A, Legendre AM, Rathore K, Wright L, Carter A, Marnett LJ (2013) Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo. Cancer Prev Res (phila) 6(5):466–476

Choi S-J, Lee H, Choe C, Shin Y-S, Lee J, Moon S-H, Kim J (2014) Establishment and characterization of a lung cancer cell line, SMC-L001, from a lung adenocarcinoma. In Vitro Cell Dev Biol-Animal 50:519–526

Article  CAS  Google Scholar 

Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Jtevens CS, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutation of the BRAF gene in human cancer. Nature 417:949–954

Article  CAS  Google Scholar 

Decker B, Parker HG, Dhawan D, Kwon EM, Karlins E, Davis DW, Ramos-Vara JA, Bonney PL, McNiel EA, Knapp DW, Ostrander EA (2015) Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer – evidence for a relevant model system and urine-based diagnostic test. Mol Cancer Res 13(6):993–1002

Article  CAS  Google Scholar 

Dhawan D, Ramos-Vara JA, Stewart JC, Zheng R, Knapp DW (2009) Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Urol Oncol 27:284–292

Article  CAS  Google Scholar 

Dvorak K, Higgins A, Palting J, Cohen M, Bruuhoeber P (2019) Immunohistochemistry with anti-BRAF V600E (VE1) mouse monoclonal antibody is a sensitive method for detection of the BRAF V600E mutation in colon cancer: evaluation of 120 cases with and without KRAS mutation and literature review. Pathol Oncol Res 25:349–359

Article  CAS  Google Scholar 

Fulkerson CM, Knapp DW (2015) Management of transitional cell carcinoma of the urinary bladder in dogs: A review. Vet J 205:217–225

Article  Google Scholar 

Garnett MJ, Marais R (2004) Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6:313–319

Article  CAS  Google Scholar 

Grassinger JM, Merz S, Aupperle-Lellbach H, Erhard H, Klopfleish R (2019) Correlation of BRAF variant V595E, Breed, histological grade and cyclooxygenase-2 expression in canine transitional cell carcinoma. Vet Sci 6:31. https://doi.org/10.3390/vetsci6010031

Article  Google Scholar 

Griffin MA, Culp WTN, Rebhun RB (2018) Lower urinary tract neoplasia. Vet Sci 5:96. https://doi.org/10.3390/vetsci5040096

Article  Google Scholar 

Haling JR, Sudhamsu J, Yen I, Sideris S, Sandoval W, Phung W, Bravo BJ, Giannetti AM, Peck A, Masselot A, Morales T, Smith D, Brandhuber BJ, Hymowitz SG, Malek S (2014) Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling. Cancer Cell 26:402–413

Article  CAS  Google Scholar 

Holderfield M, Merritt H, Chan J, Wallroth M, Tandeske L, Zhai H, Tellew J, Hardy S, Hekmat-Nejad N, Stuart DD, McCormick F, Nagel TE (2013) RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation. Cancer Cell 23:594–602

Article  CAS  Google Scholar 

Jung H, Bae K, Lee JY, Kim J-H, Han H-J, Yoon H-Y, Yoon K-A (2021) Establishment of canine transitional cell carcinoma cell lines habouring BRAF V595E mutation as a therapeutic target. Int J Mol Sci 22:9151. https://doi.org/10.3390/ijms22179151

Article  CAS  Google Scholar 

Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H, Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T (2018) Establishment and characterization of novel patient-drived osteosarcoma xenograft and cell line. In Vitro Cell Dev Biol-Animal 54:528–536

Article  CAS  Google Scholar 

Knapp DW, Glickman NW, DeNicola DB, Bonney PL, Lin TL, Glickman LT (2000) Naturally-occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer. Uro Oncol 5:47–59

Article  CAS  Google Scholar 

Knapp DW, Ramos-Vera JA, Moore GE, Dhawan D, Bonney PL, Young KE (2014) Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J 55(1):100–118

Article  CAS  Google Scholar 

Lee S, Rauch J, Kolch W (2020) Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci 21:1102. https://doi.org/10.3390/jms21031102

Article  CAS  Google Scholar 

Li WQ, Kawakami K, Ruszkiewicz A, Bennett G, Moor J, Iacopetta B (2006) BRAF mutations are associated with clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer 5:2. https://doi.org/10.1186/1476-4598-5-2

Article  CAS  Google Scholar 

Little AS, Balmanno K, Sale MJ, Newman S, Dry JR, Hampson M, Edwards PAW, Smith PD, Cook SJ (2011) Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells. Sci Signal 4(166):ra 17. https://doi.org/10.1126/scisignal2001752

Article  Google Scholar 

Liu T, Wang Z, Guo P, Ding N (2019) Electrostatic mechanism of V600E mutation-induced B-Raf constitutive activation in colorectal cancer: molecular implications for the selectivity difference between type-I and type-II inhibitors. Eur Biophys J 48:73–82

Article  CAS  Google Scholar 

Loo E, Khalili P, Beuhler K, Siddiqi I, Vasef MA (2018) BRAF V600E mutation across multiple tumor types: correlation between DNA-based sequencing and mutation-specific immunohistochemistry. Appl Immunohistochem Mol Morphophol 26:709–713

Article  CAS  Google Scholar 

Maik-Rachline G, Hacohen-Lev-Ran A, Seger R (2019) Nuclear ERK: mechanism of translocation, substrates, and role in cancer. Int J Mol Sci 20:1194. https://doi.org/10.3390/ijms20051194

Article  CAS  Google Scholar 

Maloney RC, Zhang M, Jang H, Nussinov R (2021) The mechanism of activation of monomeric B-Raf V600E. Comput Struct Biotechnol J 19:3349–3363

Article  CAS  Google Scholar 

Mochizuki H, Breen M (2015) Comparative aspects of BRAF mutations in canine cancers. Vet Sci 2:231–245

Article  Google Scholar 

Mochizuki H, Breen M (2017) Sequence analysis of RAS and RAF mutation hot spots in canine carcinoma. Vet Comp Oncol 15(4):1598–1605

Article  CAS  Google Scholar 

Mochizuki H, Kennedy K, Shapiro SG, Breen M (2015) BRAF mutation in canine cancers. PLoS ONE 10(6):e0129534. https://doi.org/10.1371/journal.pone.0129534

Article  CAS  Google Scholar 

Mutsaers AJ, Widmer WR, Knapp DW (2003) Canine transitional cell carcinoma. J Vet Intern Med 17:136–144

Article  Google Scholar 

Nagasaka T, Sasamoto H, Notohara K, Culling HM, Takeda M, Kimura K, Kambara T, MacPhee DG, Yaung J, Leggett BA, Jass JR, Tanaka N, Matsubara N (2004) Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22:4584–4594

Article  CAS  Google Scholar 

Nazarian R, Shi H, Wang QL, Kong X, Koya RC, Lee H, Chen Z, Lee M-K, Attar N, Sazegar H, Chodon T, Nelson SF, McArthur G, Sosman JA, Ribas A, Lo RS (2010) Melanomas aquire resistance to B-RAF (V600E) inhibition by RTK or N-RAS upregulation. Nature 468:973–977

Article  CAS  Google Scholar 

Norris AM, Laing EJ, Valli VEO, Withrow SJ, Macy DW, Ogilvie GK, Tomlinson J, McCaw D, Pidgeon G, Jacobs RM (1992) Canine bladder and urethral tumors: a retrospective study of 115 cases (1980–1985). J Vet Intern Med 6:145–153

Article  CAS  Google Scholar 

Packeiser E-M, Hewicker-Trautwein M, Thiemeyer H, Mohr A, Junginger J, Schille JT, Escobar HM, Nolte I (2020) Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis. PLoS ONE 15(3):e0230272. https://doi.org/10.1371/journal.pone.0230272

Article  CAS  Google Scholar 

Palyi I, Olah E, Sugar J (1977) Drug sensitivity study on glonal cell lines isolated from heteroploidy tumour cell populations. I. Dose response of clones growing in monolayer cultures. Int J Cancer 19:859–865

Article  CAS  Google Scholar 

Parikh N, Shuck RL, Nguyen T-A, Herron A, Donehower LA (2012) Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phosphor-ERK1/2 and robust tumor suppressor responses. Mol Cancer Res 10(6):845–855

Article  CAS  Google Scholar 

Patrick DJ, Fitzgerald SD, Sesterhenn IA, Davis CJ, Kiupel M (2006) Classification of canine urinary bladder urothelial tumours based on the World Health Organization/ International Society of Urological Pathology Consensus Classification. J Comp Path 135:190–199

Article  CAS  Google Scholar 

Porta C, Paglino C, Mosca A (2014) Targeting PI3K/AKT/mTOR signaling in cancer. Front Oncol 4.https://doi.org/10.3389/fonc.2014.00064

Prahallad A, Sun C, Huang S, Nicolantonio FD, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R (2012) Unresponsiveness of colon cancer to BRAF (V600E) inhibition through feedback activation of EGFR. Nature 483:100–104

Article  CAS  Google Scholar 

Rathore K, Cekanova M (2014) Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines. BMC Cancer 14: 465. http://www.biomedcentral.com/1471-2407/14/465

Reed LT, Knapp DW, Miller MA (2012) Cutaneous metastasis of transitional cell carcinoma in 12 dogs. Vet Pathol 50(4):676–681

Article  Google Scholar 

Thapa D, Stoner MW, Zhang M, Xie B, Manning JR, Guimaraes D, Shiva S, Jurczak MJ, Scott S (2018) Adropin regulates pyruvate dehydrogenase in cardiac cell via novel GPCR-MAPL-PDK4 signaling pathway. Redox Biol 18:25–32

Article  CAS  Google Scholar 

Yamasaki H, Uematsu Y, Hayashi Y, Yamashita M, Tei M, Uchida K, Ono K, Hirao H (2022) Coincidence of v-raf murine sarcoma viral oncogene homolog B mutation (V595E) with phosphorylated v-raf murine sarcoma viral oncogene homolog B in urothelial carcinoma in dogs. Can J Vet Res 86(4):286–293

Google Scholar 

Zhang B-H, Guan K-L (2000) Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J 19(20):5429–5439

Article  CAS  Google Scholar 

Zhang B-H, Guan K-L (2001) Regulation of the Raf kinase by phosphorylation. Exp Lung Res 27:269–295

Article  CAS 

留言 (0)

沒有登入
gif